Literature DB >> 18709675

Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?

Shen-Yang Lim1, Michael J Farrell, Stephen J Gibson, Robert D Helme, Anthony E Lang, Andrew H Evans.   

Abstract

Plastic changes within the striatum resulting from pulsatile dopaminergic stimulation are thought to lead to dyskinesia in patients with Parkinson's disease (PD). The basal ganglia play a role in processing pain. We hypothesized that the plastic changes that lead to dyskinesia may also mediate pain responses. Our objective was to compare the change in pain sensitivity after levodopa administration between stable responders, fluctuators without dyskinesia, and dyskinetic patients, and to compare pain sensitivity between PD and healthy subjects. Fifty patients with PD were assessed with cold water immersion after overnight withdrawal of dopaminergic medications and again after a standard levodopa challenge, and carefully classified into stable responder (n = 12), fluctuator (n = 15), and dyskinetic (n = 23) groups. Twenty age-matched controls were also tested. PD patients "off"-medication had a lower threshold (P = 0.016) and tolerance (P < 0.0001) to cold pain compared to controls. After levodopa administration, dyskinetic patients experienced a large increase in cold pain threshold (48%) and tolerance (66%) that was absent in stable responders (P = 0.038 and P = 0.015); there was no significant difference in pain sensitivity change scores between the fluctuator and either the stable responder or dyskinetic groups. Our results suggest that dyskinesia and pain may share common pathophysiological mechanisms in PD. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709675     DOI: 10.1002/mds.22111

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  21 in total

1.  Alterations of gene expression of sodium channels in dorsal root ganglion neurons of estrogen receptor knockout (ERKO) mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  Haixia Ding; Qiang Wang; Jingli Liu; Wenyi Qian; Wenjuan Wang; Jun Wang; Rong Gao; Hang Xiao
Journal:  Endocrine       Date:  2012-02-28       Impact factor: 3.633

Review 2.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

Review 3.  Integrated Approach for Pain Management in Parkinson Disease.

Authors:  Christian Geroin; Marialuisa Gandolfi; Veronica Bruno; Nicola Smania; Michele Tinazzi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

4.  Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease.

Authors:  Sandro Zambito Marsala; Michele Tinazzi; Roberta Vitaliani; Serena Recchia; Federico Fabris; Corrado Marchini; Antonio Fiaschi; Giuseppe Moretto; Bruno Giometto; Antonella Macerollo; Giovanni Defazio
Journal:  J Neurol       Date:  2010-11-17       Impact factor: 4.849

5.  Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson's disease: a correlation study.

Authors:  Estelle Dellapina; Jean Pellaprat; Djilali Adel; Jerome Llido; Estelle Harroch; Jean Baptiste Martini; Aurélie Kas; Anne Sophie Salabert; Fabienne Ory-Magne; Pierre Payoux; Christine Brefel-Courbon
Journal:  J Neural Transm (Vienna)       Date:  2019-01-31       Impact factor: 3.575

Review 6.  The epidemiology of pain in Parkinson's disease.

Authors:  Giovanni Defazio; Angelo Gigante; Paola Mancino; Michele Tinazzi
Journal:  J Neural Transm (Vienna)       Date:  2012-12-04       Impact factor: 3.575

Review 7.  Diagnosis and Management of Pain in Parkinson's Disease: A New Approach.

Authors:  Veit Mylius; Jens Carsten Möller; Stephan Bohlhalter; Daniel Ciampi de Andrade; Santiago Perez Lloret
Journal:  Drugs Aging       Date:  2021-07-05       Impact factor: 3.923

8.  Nociceptive Response to L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.

Authors:  G C Nascimento; K Bariotto-Dos-Santos; C R A Leite-Panissi; E A Del-Bel; M Bortolanza
Journal:  Neurotox Res       Date:  2018-04-02       Impact factor: 3.911

9.  Parkinson's disease patients with pain suffer from more severe non-motor symptoms.

Authors:  Cheng-Jie Mao; Ju-Ping Chen; Xiao-Yi Zhang; Yi Chen; Si-Jiao Li; Jie Li; Kang-Ping Xiong; Wei-Dong Hu; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

10.  Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations.

Authors:  Santiago Perez-Lloret; Daniel Ciampi de Andrade; Kelly E Lyons; Carmen Rodríguez-Blázquez; Kallol Ray Chaudhuri; Guenther Deuschl; Girgio Cruccu; Cristina Sampaio; Christopher G Goetz; Anette Schrag; Pablo Martinez-Martin; Glenn Stebbins
Journal:  Mov Disord Clin Pract       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.